Cargando…
LINC00973 Induces Proliferation Arrest of Drug-Treated Cancer Cells by Preventing p21 Degradation
Overcoming drug resistance of cancer cells is the major challenge in molecular oncology. Here, we demonstrate that long non-coding RNA LINC00973 is up-regulated in normal and cancer cells of different origins upon treatment with different chemotherapeutics. Bioinformatics analysis shows that this is...
Autores principales: | Karpov, Dmitry S., Spirin, Pavel V., Zheltukhin, Andrey O., Tutyaeva, Vera V., Zinovieva, Olga L., Grineva, Evgenia N., Matrosova, Vera A., Krasnov, George S., Snezhkina, Anastasiya V., Kudryavtseva, Anna V., Prassolov, Vladimir S., Mashkova, Tamara D., Lisitsyn, Nikolai A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7664178/ https://www.ncbi.nlm.nih.gov/pubmed/33171937 http://dx.doi.org/10.3390/ijms21218322 |
Ejemplares similares
-
Treatment of cancer cells with chemotherapeutic drugs results in profound changes in expression of genes encoding aldehyde-metabolizing enzymes
por: Zinovieva, Olga L., et al.
Publicado: (2019) -
LINC00973 is involved in cancer immune suppression through positive regulation of Siglec‐15 in clear‐cell renal cell carcinoma
por: Liu, Yanbin, et al.
Publicado: (2020) -
The Regulatory Network and Potential Role of LINC00973-miRNA-mRNA ceRNA in the Progression of Non-Small-Cell Lung Cancer
por: Guo, Qiang, et al.
Publicado: (2021) -
Identification of cell type–specific correlations between ERK activity and cell viability upon treatment with ERK1/2 inhibitors
por: Lebedev, Timofey D., et al.
Publicado: (2022) -
ROS Generation and Antioxidant Defense Systems in Normal and Malignant Cells
por: Snezhkina, Anastasiya V., et al.
Publicado: (2019)